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Abstract. Integrin, the cell-substrate attachment 
(CSAT) antigen, is a  complex of integral membrane 
glycoproteins whose apparent function is to mediate 
cell-substratum adhesion by serving as a  transmem- 
brane link between the extracellular matrix and ele- 
ments of the cytoskeleton. Previous attempts to sepa- 
rate the members of this complex under nondenaturing 
conditions have been successful. We have now pro- 
duced a  monoclonal antibody "G" that is specific for 
the lower molecular mass cysteine-rich band 3 of the 
complex.  Using an antibody affinity column containing 
this monoclonal antibody, it is possible to dissociate 
integrin into two fractions, one containing band 3,  the 
other containing bands  1 plus 2.  Neither fraction will 
by itself bind fibronectin, laminin, or talin. However, 
when the fractions are combined, the reconstituted 
integrin elutes from a  gel filtration column in the same 
position as the native complex, and binding activity to 
these molecules returns.  Further,  it is shown by gel 
filtration that the recognition site for the adhesion- 
disrupting monoclonal antibodies CSAT and JG22 is 
on band 3,  supporting the contention that integrin is 
an oligomer. The data presented here is consistent 
with integrin being either a  mixture of heterodimers, 
each with a  common subunit and reacting with a par- 
ticular extracellular matrix molecule, or a  single het- 
erotrimer capable of binding to several different extra- 
cellular matrix molecules. 
T 
HE adhesion of cells to an extracellular matrix is the 
end result of a complex series of interactions involving 
specific elements of  the extracellular matrix, receptors 
on the cell surface, and constituents of the cytoskeleton. A 
group of cell surface glycoproteins originally designated the 
cell-substrate attachment (CSAT)'  complex, but more re- 
cently named integrin (26), has been implicated as the trans- 
membrane  linker  mediating these  molecular  interactions 
during cell-substrate adhesion (13). Integrin was  isolated 
using a monoclonal antibody that inhibits cellular adhesion 
to either fibronectin or laminin (14, 18). Integrin as isolated 
from chick ceils consists of at least three glycoproteins with 
an average molecular mass of 140 kD (15). It interacts di- 
rectly with fibronectin and laminin. This interaction can be 
inhibited with either a monoclonal antibody against integrin 
or the cell-binding tetrapeptide from fibronectin (14). Inte- 
grin also binds to talin, a molecule thought to be important 
in linking elements of the cytoskeleton with the cell surface. 
This  talin-integrin interaction involves  a  site on  integrin 
different from that which binds fibronectin and laminin (13). 
A complex with identical properties has been independently 
isolated  from chick cells using  the  monoclonal antibody 
JG22 (1, 9,  11). 
The glycoproteins of which integrin is composed differ 
from one another in size, peptide composition, and serologi- 
cal reactivity (15, 11). The gene for band 3 of integrin has 
been cloned and sequenced (26).  The data show it to consist 
of 803 amino acids arranged in such a way as to have a large 
1.  Abbreviation  used in  this paper:  CSAT, cell  substrate attachment. 
external NH2-terminal domain with cysteine-rich regions, a 
single transmembrane segment, and a short COOH-terminal 
cytoplasmic domain. This component and band 2 of integrin 
are both phosphorylated after viral transformation (12). It 
has not been possible to separate integrin glycoproteins ex- 
cept under the denaturing conditions of nonreduced SDS 
PAGE. This has led to the suggestion that these glycoproteins 
reside and function as an integral membrane complex (3). To 
test this hypothesis, we have produced a monoclonal anti- 
body that allows the fractionation of integrin.  Using this 
monoclonal antibody, we have been able to show that integrin 
exists as an oligomer and to evaluate the requirement of its 
integrity for both antibody and ligand binding. The results 
of these experiments show that the oligomeric nature of inte- 
grin is required for binding to fibronectin, laminin, and talin, 
and that the epitope recognized by the adhesion-disrupting 
monoclonal antibody CSAT is on the cysteine-rich band 3 
glycoprotein of the complex. 
Materials and Methods 
Chick Fibroblast Cultures 
Fibroblasts were prepared and cultured as previously described (6).  Cells 
were grown in Dulbeccds modified  Eagle's  medium containing  10%  fetal 
bovine serum. 
Purification of  lntegrin 
[35S]methionine labeling of cell cultures was carried out in methionine-free 
Eagle's minimum essential  medium as previously described (13). The inte- 
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labeled cells or decapitated and eviscerated  10-d-old  chick embryos as 
previously described 05). Briefly, embryos were extracted in 10 mM Tris- 
acetate buffer,  pH 8.0, containing 0.5 mM Ca  ++, 2  mM phenylmethylsul- 
fonyl fluoride, and 0.5% NP-40 (TNC). After centrifugation at 50,000 g for 
30 min, the supernate was precipitated with acetic acid (16), neutralized, 
and applied to  an  antibody affinity column containing  l0  mg of CSAT 
monoclonal antibody per millileter of packed volume (18). The antigen was 
eluted with 50  mM diethylamine, pH  11.5, immediately neutralized, di- 
alyzed extensively against TNC,  and stored at  -70°C until used. 
MonoclonaI  Antibody Production 
Monoclonal antibodies were produced as described previously (18). In- 
traperitoneal injections of 50 Ixg/rnl of purified integrin mixed with equal 
volumes of incomplete Freund's adjuvant were administered to BALB/c 
mice three times at 10-d intervals. 5 d after the final injection, spleens were 
harvested and cells fused with plasmacytoma cell line SP 2/0-Ag 14. Super- 
nares from the resulting hybridomas were screened for antibody production 
by an ELISA assay performed in microtiter wells coated with purified inte- 
grin. Hybridomas selected in this manner were cloned by limiting dilution, 
the clones rescreened by the ELISA assay, and positive clones recloned. Af- 
ter the final ELISA assay, positive clones were assayed for their ability to 
immunoblot purified integrin, and selected hybridomas were characterized 
further as described in Results. The following monoclonal antibodies were 
used in the experiments presented here: CSAT, characterized as described 
previously (18); G, specific for band 3 of integrin; and B, specific for band 
1 of integrin. B and G  monoclonal antibodies are of the class IgGi. 
Immunoprecipitation 
200 Ixl of [35S]methionine-labeled  integrin in TNC buffer containing 0.15 
M  NaCI  (TNC-NaCI)  and 0.2%  BSA were preabsorbed first with 25  gl 
packed volume of protein A Sepharose (Pharmacia Fine Chemicals, Upp- 
sala, Sweden) prepared according to manufacturer's instructions and then 
with 25  gl packed volume of protein A Sepharose saturated with affinity- 
purified rabbit anti-mouse heavy and light chain IgG (Cappel Laboratories, 
Div. Cooper Biomedical, Inc., Malvern, PA). The preabsorbed antigen was 
then mixed with 20 gg purified monoclonal antibody and allowed to stand 
for 60 min at 4°C. 50 gg of rabbit anti-mouse IgG was then added and the 
mixture incubated another 60 rain at 4°C, after which time it was added to 
a 50-gl packed pellet of protein A Sepharose and mixed constantly at 4°C 
for  another  60  min.  The  immune  complex absorbed to  the protein A 
Sepharose was centrifuged and washed five times in TNC-NaCI,  finally 
resuspended in sample buffer, and analyzed by SDS PAGE under nonreduc- 
ing conditions (14). 
Antibody Affinity Chromatography 
Purified immunoglobulin was bound to cyanogen bromide-activated Sepha- 
rose (Pharmacia Fine Chemicals) at a concentration of 10 mg/ml packed vol- 
ume of hydrated cyanogen bromide Sepharose, according to the manufac- 
turer's instructions. Ethanolamine was used to block all activated sites not 
saturated with immunoglobulin. Water-jacketed columns were packed with 
1-3 ml bed volume of solid-phase material. Material was applied to each 
column in TNC-NaCI at a flow rate of 0.3-0.5 ml/min. The column was 
washed with at least 50 column volumes of TNC-NaC1,  and eluted with 
50 mM diethylamine, pH 11.5, containing 0.5%  NP-40 and 0.15 M NaCI. 
Samples were/immediately brought to pH 7.5 with 0.1 M HCI and dialyzed 
against TNC-NaCI. 
Gel Electrophoresis 
Samples were analyzed by SDS PAGE using 7%  acrylamide gels by the 
method of Laemmli (17) without the addition of reducing agents. Materials 
used for immunoblots were transferred to nitrocellulose paper as previously 
described (15). Alternatively, proteins were detected by silver staining (19). 
Immunoblotting 
Nitrocellulose paper containing the samples was cut into  strips and in- 
cubated with 4% BSA in PBS for 60 min and then exposed to the appropriate 
monoclonal antibody for 60 min at room temperature. The strips were then 
extensively washed with PBS containing BSA and then exposed to affinity- 
purified rabbit anti-mouse heavy and light chain IgG. After another 60 min, 
the samples were washed once again and exposed to t2SI-protein A  (ICN 
Radiochemicals, Irvine, CA). The strips were subsequently washed and au- 
toradiographed using an enhancing screen and Kodak X-Omat AR film. 
Equilibrium Gel Filtration Assay 
for Macromolecular  Associations 
This assay was carried out as previously described (14) using a 0.2  x  30-cm 
column of Ultrogel AcA22 (LKB Instruments, Inc., Gaithersburg, MD). 
The void volume of this column was 0.54 ml and the included volume was 
1.5 ml. The flow characteristics and calibration of this column have been 
previously described (14, 18). When interactions between integrin or any 
of its derivatives with other macromolecules were assayed, the column was 
saturated with one column volume of the desired macromolecule at the ap- 
propriate concentration in TNC-NaCI before addition of the test mixture. 
60-gl fractions were collected and radioactivity counted in a scintillation 
counter (Intertechnique, Plaisir, France). The reproducibility of  this column 
has been previously documented (13, 14). 
Figure 1.  Specificity of monoclonal antibodies for individual inte- 
grin glycoproteins. Purified integrin, first four lanes, or an NP-40 
extract of chick embryos, last three lanes, were subjected to SDS 
PAGE under nonreducing conditions. Material  was transferred to 
nitrocellulose paper, and strips were cut and exposed to the appro- 
priate monoclonal antibody. Monoclonal antibody bindiag was de- 
tected using rabbit anti-mouse IgG and ~25I-protein  A  as described 
in Materials and Methods.  [35S]Methionine-labeled integrin (lane 
1);  immunoblot  of integrin  using  G  monoclonal  antibody  (lane 
2); mixture of G and B monoclonal antibody (lane 3); and B mono- 
clonal  antibody  (lane  4);  immunoblot  of  chick  embryo  NP- 
40 extract using G  monoclonal antibody (lane 5); mixture of B and 
G  monoclonal  antibody  (lane  6);  and  B  monoclonal  antibody 
(lane  7). 
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Characterization  of  Monoclonal Antibody Specificity 
Hybridomas were  selected  as  described  in  Materials  and 
Methods after injection of mice with purified, nondenatured 
integrin. After screening for integrin specificity, ascites fluid 
was prepared with selected hybridomas. Antibodies isolated 
from the ascites fluid were used in Western blots to test for 
reactivity with individual glycoproteins. The results of such 
a screen using two monoclonal antibodies designated B and 
G  are  shown in  Fig.  1.  Either purified integrin  (first four 
lanes) or an NP-40 extract of chick cells (last three lanes) was 
subjected to SDS PAGE under nonreducing conditions and 
transferred  to  nitrocellulose.  Individual  lanes  were  then 
reacted  with  the  appropriate monoclonal antibody.  35S-Ia- 
Figure  2.  Selective  immunoprecipitation  of  [35S]methionine- 
labeled ir~tegrin with G monoclonal antibody. Radioactive integrin 
was  mixed  with  CSAT monoclonal  antibody  (lane  1)  or  G 
monoclonal antibody (lane 2). Rabbit anti-mouse heavy and light 
chain was added to each mixture, and the complex absorbed to pro- 
tein A Sepharose. Absorbed complex was eluted with sample buffer 
and separated on nonreduced  SDS PAGE. 
beled antigen was electrophoresed in  an adjacent lane  for 
use as a position marker. It is clear that the G  monoclonal 
antibody  reacts  predominantly  with  the  lower  molecular 
mass member of the complex designated band 3.  There is 
some trace reactivity in the vicinity of the highest molecular 
mass band  1  region  of the  blot and  also  in  a  still  higher 
molecular  mass  region.  These  probably  represent  aggre- 
gates, as they do not appear in blots of whole NP-40 extracts 
of cells (last three lanes).  A  second monoclonal antibody 
designated  B  reacts  primarily  with  the  higher  molecular 
weight band of integrin.  However, again, there is trace re- 
activity with lower molecular mass material. This is insig- 
nificant when compared with that of band  1 and may well 
represent proteolytic fragments. Immunoblots of an unfrac- 
tionated  NP-40  extract  from chicken  embryos  (last three 
lanes) further demonstrate the specificity of these two mono- 
clonal antibodies. Here, each antibody reacts only with ma- 
terial migrating in the appropriate molecular mass region of 
the gel. Thus, G monoclonal reacts only with material in the 
band 3 region of the gel and B monoclonal only with material 
from the band 1 region of the gel. This was further confirmed 
when both B and G antibodies were included in the blotting 
procedure. 
To examine the specificity of the G  monoclonal antibody 
under nondenaturing conditions, NP-40 extracts from chick 
fibroblasts labeled with  [35S]methionine  were immunopre- 
cipitated with both CSAT monoclonal antibody and G mono- 
clonal antibody.  The  results  are  shown  in  Fig.  2.  Lane 1 
contains material immunoprecipitated with the CSAT mono- 
clonal antibody.  Lane 2  contains material immunoprecipi- 
tated with the G monoclonal antibody. It immunoprecipitates 
only material migrating  in the region of band 3.  Identical 
results were obtained if the G monoclonal antibody was used 
to immunoprecipitate purified integrin. 
Fractionation of  lntegrin Using a Monoclonal Antibody 
The immunoprecipitation results indicated that the G mono- 
clonal antibody might be used to separate integrin into two 
component parts, one enriched in band 3 glycoprotein and 
the other containing a mixture of bands 1 and 2. To do this, 
an  inununoaffinity  column  was  constructed  using  the  G 
monoclonal antibody. The results of passing purified integrin 
over such a  column are shown in Fig.  3.  Silver staining of 
the CSAT complex before passage over the G affinity column 
is shown in lane 1. Lane 2 shows a silver stain of the material 
eluted from the G  affinity column. It is clearly enriched in 
band 3 glycoprotein. Lane 3 shows the material that did not 
bind to the affinity column. It contains primarily band 1 ma- 
terial with traces of band 2 material. Because of the dilution 
of material during the process, band 2 is not clearly visible 
on the gel.  However, when 35S-labeled  integrin is fraction- 
ated in an identical manner, both band 1 and 2 material are 
readily visible (see Fig. 4). Variations in the relative amount 
of material in each band are due to differences in specific ac- 
tivity and sensitivity to staining procedures.  Material used 
in these studies has been submitted to silver staining and au- 
toradiography after nonreduced SDS PAGE to monitor the 
possible contamination by other proteins and the amount of 
proteolytic  degradation  of integrin  that  may occur during 
isolation.  The latter may be responsible for the occasional 
impression of more than one component in the band 3 region 
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affinity column. Integrin purified from chick embryos was passed 
over a  1-ml column containing G monoclonal antibody conjugated 
to  cyanogen bromide Sepharose  at a  concentration  of 10 mg/ml 
packed volume of Sepharose.  Absorbed material was eluted with 
50  mM  diethylamine,  pH  11.5, and  immediately  neutralized  as 
detailed in Materials and Methods. Silver-stained nonreduced SDS 
PAGE of integrin applied to column (lane 1 ), material eluted from 
column (lane 2), and material not bound to column (lane 3). 
of a  gel.  The material seen near the bottom of each lane is 
a contaminant in the tracking dye. These results demonstrate 
that the G  monoclonal antibody can be used to produce two 
fractions, one enriched in band 3 glycoprotein, and the other 
containing  primarily band  1 and  2  glycoproteins. 
The  elution  profiles  of  [35S]methionine-labeled  band  1 
plus  2  and  band  3  fractions  from  an  AcA22  gel  filtration 
column  are  shown  in  Fig.  4.  The  reproducibility  of this 
column has been previously documented  (13, 14).  The elu- 
tion profile for band 1 plus 2 is rather broad, with a peak just 
behind that of integrin  (VAg).  This more than likely reflects 
the heterogeneity of the sample in that it contains primarily 
band  1  and  2  glycoproteins,  with  a  small  amount  of con- 
taminating band 3. This is shown in the insert, the first lane 
of which shows an SDS PAGE separation of pooled fractions 
14-20.  The band  3  glycoprotein elutes  from this  same col- 
umn in a position behind  that of the band  1 plus 2  mixture, 
producing  a  sharper  elution  profile.  SDS  PAGE separation 
of material eluting  in the band  3  region  shows  this  to con- 
tain primarily band 3 glycoprotein material (second lane in 
insert). 
The Binding Site  for CSAT and JG22 
Monoclonal Antibodies Is on Band 3 
The CSAT monoclonal  antibody and  an independently  iso- 
lated monoclonal antibody, JG22, have been used to identify 
and isolate integrin (9,  18).  The antigenic site recognized by 
these antibodies is sensitive to denaturation;  therefore, it has 
not been possible to determine  which  band of the  integrin 
complex contains the antibody-binding epitope, or if it con- 
sists of a  configuration  requiring  all  three  members of the 
complex. To test these possibilities,  CSAT monoclonal anti- 
body was  mixed with  [35S]methionine-labeled  band  1 plus 
2,  or band 3  (see Fig.  4) before addition  to the AcA22  gel 
filtration column.  The results are shown in Fig.  5.  In Fig.  5 
A,  a  slight  shift,  though  within  experimental  error,  of the 
35S-labeled band  1 plus 2  elution profile is seen in the pres- 
ence of CSAT monoclonal antibody. This is probably due to 
the small amount of contaminating band 3 in the preparation 
(see insert,  Fig. 4) as Fig.  5 B  shows a  major change in the 
elution profile of the band 3 material in the presence of CSAT 
monoclonal antibody.  The same results  were obtained with 
the JG22 monoclonal antibody. Denaturing the band 3 glyco- 
protein by boiling or by reduction  with dithiothreitol  before 
the addition of CSAT or JG22 monoclonal antibodies abol- 
ished all recognition of the glycoprotein by either antibody. 
It appears that band 3 contains the major epitope recognized 
by the CSAT or the JG22 monoclonal antibodies.  This epi- 
tope  would  appear to be  sufficiently  far removed from the 
sites involved in the association of band 3 with bands  1 and 
2 in the complex, so as not to effect the integrity of the com- 
plex  in  a  manner  similar  to  that of the  G  monoclonal  an- 
tibody. 
Figure 4.  AcA22  gel filtration pattern of band  1 plus 2, and band 
3  material  from  a  G  monoclonal  antibody  affinity  column. 
[35S]methionine-labeled  integrin  was  fractionated on  a  G  mono- 
clonal antibody affinity  column to yield fractions containing pre- 
dominantly band 1 plus 2, or band 3. The samples were applied to 
a 0.2  x  30-cm AcA22 column and 60-I.tl fractions collected. Band 
1 plus 2, (open circles, broken line); band 3, (solid circles, solid 
line); Vag,  peak elution position for intact  integrin.  Insert, non- 
reduced  SDS  PAGE of material  from bands  1 plus  2,  fractions 
14-20 (first  lane),  and band 3,  fractions  16-20 (second lane). 
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for Binding to Extracellular Matrix and 
Cytoskeletal Constituents 
To determine  whether  integrin must remain intact for it to 
bind to elements of the extracellular matrix, band 1 plus 2, 
band 3,  or reconstituted  integrin  were mixed with laminin 
and applied to a gel filtration column pre-equilibrated  with 
laminin at 400 Ixg/ml. With either band 1 plus 2 or band 3, 
there was no change in the elution profile (Fig. 6, A and B). 
However,  when  the  complex  was  reconstituted  by  mixing 
band  1 plus 2  and band 3  in the presence of the ligand just 
before addition to the gel filtration column, a peak of radio- 
activity appeared in the void volume (Fig. 6 C), demonstrat- 
ing that reconstituted integrin binds laminin.  The formation 
of this complex was inhibited by both the CSAT monoclonal 
antibody  and  by the RGDS  cell-binding  tetrapeptide  from 
fibronectin,  as shown previously (14). 
The elution profile of reconstituted  integrin differed from 
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Figure 5. The binding of CSAT monoclonal antibody to [35S]me- 
thionine-labeled band 3 glycoprotein. Band 1 plus 2, or band 3 gly- 
coprotein preparations shown in Fig. 4 were mixed with 20 Ixg/ml 
CSAT monoclonal antibody and applied to a 0.2  ×  30-cm AcA22 
column; 60-~tl fractions were collected. (A) Bands  1 plus 2 alone 
(open  circles, broken  line),  and  bands  1  plus  2  plus  CSAT 
monoclonal antibody (solid circles, solid line); (B) band 3 alone 
(open circles, broken line), band 3 plus CSAT monoclonal antibody 
(solid circles, solid line).  Vo, void volume; VAg, elution position 
of integrin;  V% total inclusion volume of the column. 
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Figure 6.  Laminin binding to reconstituted integrin.  [3SSlmethio- 
nine-labeled band 1 plus 2, band 3, or reconstituted integrin were 
mixed with 400 gg/ml laminin and applied to a 0.2 x  30-cm AcA22 
column pre-equilibrated with the same concentration of laminin; 
60-gl fractions were collected. (el) Bands 1 plus 2 alone (open cir- 
cles,  broken  line); bands  1 plus  2  plus  laminin  (solid  circles, 
solid line); (B) band 3 alone (open circles, broken line); band 3 plus 
laminin (solid circles, solid line); ( C) reconstituted integrin plus 
laminin (solid circles, solid line); Vo, void volume, YAg, elution 
position of integrin,  VT, total inclusion volume of the column. 
that of either band 3 or the mixture of bands  1 plus 2  (cf. 
Fig. 6, A-C). The reconstituted complex reproducibly eluted 
as a relatively sharp peak with a higher effective Stokes ra- 
dius in precisely the same position as native integrin.  SDS 
PAGE of the leading and trailing fractions showed all three 
bands present as in the original integrin preparation. Parallel 
experiments were performed with sucrose gradient centrifu- 
gation with analogous results (not shown). These results, to- 
gether with previously reported hydrodynamic (12,  14) and 
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Figure 7. Fibronectin binding to reconstituted integrin. [35S]methi- 
onine-labeled band 1 plus 2, band 3, or reconstituted integrin were 
mixed with 400 I.tg/ml fibronectin and applied to a 0.2  ×  30-cm 
AcA22 column pre-equilibrated with  the  same concentration of 
fibronectin; 60-pl fractions were  collected.  (A)  Bands  1 plus 2 
alone (open circles,  broken  line),  bands 1 plus 2 plus fibronectin 
(solid circles,  solid line);  (B) band 3 alone (open  circles,  broken 
line), band 3 plus fibronectin (solid circles, solid line); (C) recon- 
stituted  integrin alone (open  circles,  broken  line),  reconstituted 
integrin plus fibronectin (solid circles, solid line), Vo, void volume; 
VAg, elution position of integrin; VT,  total  inclusion volume of 
column. 
biochemical data (15), show unequivocally that these glyco- 
proteins exist as an oligomeric complex. 
The ability of the fractionated integrin to bind fibronectin 
was similarly tested.  When band  1 plus 2 or band 3 alone 
was  mixed  with  400  Ixg/ml  of fibronectin,  there  was  no 
change in the elution profile (Fig.  7).  However, the profile 
of the  reconstituted  complex  mixed  with  fibronectin  was 
shifted toward the void volume of the column in a  manner 
similar to that previously reported (14). This change in elu- 
tion profile was  inhibited by the RGDS cell-binding tetra- 
peptide from fibronectin (14). 
Integrin also binds talin (13), a 215-kD protein thought to 
play a role in the attachment of cytoskeletal elements to the 
cytoplasmic surface of the plasma membrane (4, 5). Again, 
when either band 1 plus 2 or band 3 alone was mixed with 
talin before running on a gel filtration column equilibrated 
with  talin,  no  alteration  in the elution profile  of the  35S- 
labeled  glycoprotein was  detected  (Fig.  8,  A  and B).  The 
ability  to  bind talin  was  restored  upon  reconstituting  the 
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Figure 8.  Talin binding to reconstituted integrin.  [35S]methionine- 
labeled band 1 plus 2, band 3, or reconstituted integrin were mixed 
with 400 pg/ml talin and applied to a 0.2 x  30-cm AcA22 column 
pre-equilibrated with the same concentration of talin;  60-pl frac- 
tions were collected. (A) Bands 1 plus 2 alone (open circles, broken 
line), bands 1 plus 2 plus talin (solid circles,  solid line);  (B), band 
3 alone (open circles,  broken line), band 3 plus talin (solid circles, 
solid line);  (C) reconstituted integrin alone (open circles,  broken 
line), reconstituted integrin plus talin (solid circles, solid line). Vo, 
void volume; VAg, elution position of integrin; VT, total inclusion 
volume of the column. 
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to that noted when the reconstituted complex was mixed with 
fibronectin. The binding site for talin is, however, distinct 
from that of fibronectin in that talin-binding is insensitive to 
the presence of the fibronectin cell-binding tetrapeptide (13). 
Discussion 
Integrin consists of at least three glycoproteins that probably 
serve as a transmembrane link between the extracellular ma- 
trix and cytoskeletal-associated proteins required for cell- 
substratum adhesion and cell migration (1, 9,  11, 13-15, 18). 
The members of this complex have not previously been sepa- 
rated, except under denaturing conditions. Therefore, it has 
not been possible to determine whether the three glycopro- 
teins  of the  complex co-purify because  they  exist  as  an 
oligomer,  or if they represent three glycoproteins with  a 
common antigenic site recognized by the adhesion-disrupt- 
ing monoclonal antibodies CSAT and JG22 (9, 18). Further, 
if they do exist as a true oligomer, the question arises as to 
the functional requirement for the oligomeric configuration. 
We have now produced a monoclonal antibody designated G 
that is able to dissociate the complex under nondenaturing 
conditions. When the purified CSAT complex was passed 
over a G monoclonal antibody affinity column, band 3 glyco- 
protein bound to the column while bands  1 and 2  passed 
through.  Each  of these fractions eluted from an  Ultrogel 
AcA22 column nearer the included volume than the intact 
complex. However, when the two fractions were combined, 
the reconstituted complex co-eluted with the native oligo- 
mer, suggesting that the dissociated and reconstituted com- 
plex could be used to address these questions. 
The ability of band  1 plus 2 and band 3 fractions from a 
G  antibody  affinity column to  bind  the  CSAT and  JG22 
monoclonal antibodies was compared by gel filtration. Only 
band 3 glycoprotein was recognized by these two antibodies. 
The fact that the CSAT and JG22 antibodies bound only to 
band 3 and yet could be used to co-purify band 1 and 2 glyco- 
proteins further confirms the oligomeric nature of integrin 
and eliminates the possibility that the glycoproteins are co- 
purified because they share a common epitope recognized by 
these two monoclonal antibodies. The portion of band 3 rec- 
ognized by the CSAT and JG22 antibodies is important to the 
function of the complex as a receptor for extracellular matrix 
molecules.  Blocking  this  site  prevents  direct  binding  to 
fibronectin or laminin (1,  14), thus inhibiting cell adhesion 
and spreading. Polyclonal antibodies raised against purified 
band 3 glycoprotein also inhibit cell attachment and spread- 
ing on defined substrata (unpublished data), further substan- 
tiating that band 3 glycoprotein contains regions controlling 
the binding  of integrin to extracellular matrix molecules. 
This site is distinct from that recognized by the G  mono- 
clonal antibody, which has no effect on cellular adhesion. 
The monoclonal antibodies, CSAT and G, should be useful 
in identifying peptides from the regions of band 3 that con- 
trol complex integrity and receptor function. 
To determine if integrin must remain an oligomer to act 
as  a  receptor for fibronectin, laminin,  or talin,  the disso- 
ciated and reconstituted complex was  subjected to equilib- 
rium gel filtration in the presence of each of these ligands. 
This method has proven extremely reproducible in our hands 
(13,  14). The experiments  reported here were repeated at 
least three times using three independent integrin prepara- 
tions with essentially the same results. That is, the shift in 
elution profile upon reconstitution of integrin and addition of 
the various ligands was reproducible to the fraction using the 
column calibrated as previously described (13, 14). When 
bands 1 plus 2 or band 3 glycoproteins were passed over the 
column in the presence of any of these ligands,  no ligand 
receptor interaction was  detected.  However, when band  1 
plus 2 glycoproteins were mixed with band 3 glycoprotein, 
the molecules were functionally and hydrodynamically re- 
constituted. They could now bind the various ligands,  and 
they eluted in a position on the AcA22 column characteristic 
of intact integrin. The binding activity of the reconstituted 
complex resembled that of nondissociated integrin in that it 
was  sensitive to  the  fibronectin cell-binding  tetrapeptide, 
RGDS, and to the CSAT monoclonal antibody. These experi- 
ments  support the contention that integrin must be oligo- 
meric to function as a receptor. 
While these data show that neither band 3 by itself nor 
band 1 plus 2 can bind any of the ligands tested, the quater- 
nary structure required for activity is not clear. In addition 
to a heterotrimer of bands 1, 2, and 3, other possible combi- 
nations, such as heterodimers comprised of band 2 plus 3 or 
band  1 plus  3,  might also  produce active configurations. 
Relevant to this point is the fact that, while preparations of 
integrin always contain all three glycoproteins, there is a dis- 
crepancy between the sedimentation data and the theoretical 
molecular mass of a heterotrimer (3). As pointed out previ- 
ously, when corrections are made for detergent binding, the 
calculated molecular mass of the material migrating in a su- 
crose gradient with a s2o. w of 8.6 is between that of a het- 
erodimer and a heterotrimer. While the molecular mass esti- 
mates from such data are subject to error due to incomplete 
knowledge of the partial specific volume of the complex, es- 
pecially in the presence of detergent, and the inaccuracy of 
the estimation of the apparent molecular mass of the various 
integrin glycoproteins by SDS PAGE, it is quite possible that 
the  minimum  functional unit  is  a  heterodimer containing 
band 3 plus one of the others. 
There are both similarities and differences between inte- 
grin and extracellular matrix-binding receptors from mam- 
malian cells. The integrin molecules from mammalian cells 
that bind fibronectin consist of two glycoproteins, not three 
(2, 7, 8, 20-23, 25). Further, in mammalian cells, different 
receptors  appear  to  be  involved  in  fibronectin,  laminin, 
vitronectin, and collagen adhesion. These receptors are dis- 
tinguished genetically (10), serologically (2), and biochemi- 
cally (2, 7,  8, 20-23, 25).  In contrast, integrin from avian 
cells may serve as a universal receptor for fibronectin, lami- 
nin  (14),  collagen,  and  vitronectin (Horwitz,  A.  E,  and 
C. A. Buck, unpublished observations). However, the bind- 
ing of all integrin-like molecules regardless of their source 
to their respective ligands is similar in that it is blocked by 
the RGDS cell-binding tetrapeptide. Also, the lower molecu- 
lar mass constituent of each of these complexes is a cysteine- 
rich glycoprotein with a great deal of internal disulfide bond- 
ing, suggesting, perhaps, a common subunit in each of these 
receptors. If this were the case in the avian system, integrin 
could be a  mixture of receptors each  having  the  band  3 
subunit in common. The individual receptors in the mixture 
isolated  with  the  CSAT  or  JG22  monoclonal  antibodies 
would  then  resemble  the  heterodimeric  complexes  from 
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gesting that band 3 of both integrin and the collagen receptor 
from rat cells contains a common serologically cross-reac- 
tive  epitope  (C.  Altmann,  T.  Borg,  A.  E  Horwitz,  and 
C. A. Buck, unpublished observations). If these data can be 
extended to surface membrane receptors for other extracellu- 
lar matrix molecules, it may be that there is indeed a family 
of integrin-like molecules all sharing a common band 3-like 
subunit, and, as proposed by Ruoslahti and Pierschbacher 
(24),  all  sensitive  to  the  arg-gly-asp  cell  recognition  se- 
quence  from  fibronectin.  A  similar  suggestion  has  been 
made for position-specific  antigens expressed  during Dro- 
sophila development (27). Immunoprecipitation studies sug- 
gest that these antigens represent a family of developmen- 
tally regulated molecules whose tissue specificity is achieved 
by combining different molecules  with a  common subunit 
(28). In this case, the common subunit is also a cysteine-rich 
protein whose apparent molecular mass increases upon SDS 
PAGE performed under reducing conditions. 
If, on the other hand, integrin functions as a heterotrimer 
capable  of  binding  more  than  one  extracellular  matrix 
molecule,  it would resemble  the gplIb/IIIa  complex  from 
platelets.  This complex binds several ligands,  including fi- 
bronectin, fibrinogen, and von Willebrand factor,  by an arg- 
gly-asp-mediated mechanism.  Whatever the precise nature 
of the quaternary  structure of integrin,  its  oligomeric  in- 
tegrity is required for it to function as a receptor for extracel- 
lular matrix and cytoskeletal-associated molecules. 
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